CD33 and chronic myelogenous leukemia, BCR-ABL1 positive: We also confirmed by flow cytometry that CD33 was expressed on CML CD34+ cells’ surface (Figure S1) and that it being on the cell surface did not significantly change after IM treatment (Figure S2).